Brief: Quantum Biopharma Submits Investigational New Drug (Ind) Application To United States Food And Drug Administration (FDA)
01/04/2026 13:33
April 1 (Reuters) - Quantum Biopharma Ltd QNTM.CD: QUANTUM BIOPHARMA SUBMITS INVESTIGATIONAL NEW DRUG (IND) APPLICATION TO UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA) FOR LUCID-MS PHASE TWO CLINICAL TRIAL IN MULTIPLE SCLEROSIS QUANTUM BIOPHARMA LTD - ANTICIPATED FDA RESPONSE TO IND SUBMISSION IN Q2 2026 QUANTUM BIOPHARMA LTD - PHASE 2 TRIAL INITIATION FOR LUCID-MS PLANNED FOR Q2 2026 QUANTUM BIOPHARMA LTD - PHASE 2 INTERIM DATA FOR LUCID-MS PROJECTED FOR Q4 2026 Source text: ID:nGNX8qDM0X Further company coverage: QNTM.CD ((Reuters.Briefs@thomsonreuters.com;))